S
Susanne Unverzagt
Researcher at Martin Luther University of Halle-Wittenberg
Publications - 80
Citations - 3146
Susanne Unverzagt is an academic researcher from Martin Luther University of Halle-Wittenberg. The author has contributed to research in topics: Medicine & Cardiogenic shock. The author has an hindex of 21, co-authored 62 publications receiving 2616 citations.
Papers
More filters
Journal ArticleDOI
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner,Nicholas Syn,Markus Moehler,Wilfried Grothe,Wei Peng Yong,Bee Choo Tai,Jingshan Ho,Susanne Unverzagt +7 more
TL;DR: Assessment of the efficacy of chemotherapy versus best supportive care (BSC), combination versus single-agent chemotherapy and different chemotherapy combinations in advanced gastric cancer found chemotherapy extends overall survival (OS) by approximately 6.7 months more than BSC.
Journal ArticleDOI
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
Roland Prondzinsky,Henning Lemm,Michael Swyter,Nikolas Wegener,Susanne Unverzagt,Justin M. Carter,Martin Russ,Axel Schlitt,Ute Buerke,Arnd Christoph,Hendrik Schmidt,Matthias Winkler,Joachim Thiery,Karl Werdan,Michael Buerke +14 more
TL;DR: In this randomized trial addressing addition of IABP in CS patients, mechanical support was associated only with modest effects on reduction of APACHE II score as a marker of severity of disease, improvement of cardiac index, reduction of inflammatory state, or reduction of BNP biomarker status compared with medical therapy alone.
Journal ArticleDOI
[S3-guideline exocrine pancreatic cancer].
Thomas Seufferlein,M. Porzner,Thomas Becker,V. Budach,Güralp O. Ceyhan,Irene Esposito,Rainer Fietkau,M. Follmann,Helmut Friess,Peter R. Galle,M. Geißler,Matthias Glanemann,Thomas M. Gress,Volker Heinemann,W. Hohenberger,Ulrich T. Hopt,Jakob R. Izbicki,Ernst Klar,Jörg Kleeff,I. Kopp,Frank Kullmann,T. Langer,Jan M. Langrehr,Markus M. Lerch,Matthias Löhr,Jutta Lüttges,Manfred P. Lutz,Julia Mayerle,Patrick Michl,P. Möller,M. Molls,Marc W. Münter,M. Nothacker,Helmut Oettle,Stefan Post,Anke Reinacher-Schick,Christoph Röcken,Elke Roeb,H. Saeger,RM Schmid,Wolff Schmiegel,Michael H. Schoenberg,Jens T. Siveke,Martin Stuschke,Andrea Tannapfel,Waldemar Uhl,Susanne Unverzagt,B. van Oorschot,Y. Vashist,Jens Werner,Emre F. Yekebas +50 more
Journal ArticleDOI
Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
Susanne Unverzagt,Michael Buerke,Antoinette de Waha,Johannes Haerting,Diana Pietzner,Melchior Seyfarth,Holger Thiele,Karl Werdan,Uwe Zeymer,Roland Prondzinsky +9 more
TL;DR: There is no convincing randomised data to support the use of IABP in infarct-related cardiogenic shock, however, available evidence suggests that IABp may have a beneficial effect on some haemodynamic parameters.
Journal ArticleDOI
Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
Roland Prondzinsky,Susanne Unverzagt,Martin Russ,Henning Lemm,Michael Swyter,Nikolas Wegener,Ute Buerke,Uwe Raaz,Henning Ebelt,Axel Schlitt,Konstantin M. Heinroth,Johannes Haerting,Karl Werdan,Michael Buerke +13 more
TL;DR: Additional IABP treatment did not result in a significant hemodynamic improvement compared with medical therapy alone in a randomized prospective trial in patients with CS following PCI, and the use and recommendation for IABp treatment in CS remain unclear.